Roberts Mlotkowski Safran & Cole, P.C.
PDE 10a inhibitors for the treatment of type II diabetes
Disclosed are compounds, compositions and methods for treating Type II diabetes. Such compounds are represented by Formula (I) as follows:wherein R1, R2, L, and Q are defined herein.
Janssen Pharmaceutica, NV
C A A
C07D A61P A61P
inventional inventional inventional
Kenneth J. Sanath K. Hui Carl R. Daniel J. Wing S. Raymond J. Jinsheng Yu-Kai Mark R.
Wilson Meegalla Huang Illig Parks Cheung Patch Chen Lee Player